# Changelog


## üîç 05.01.2026 UPDATE v0.3.1

### –î–æ–±–∞–≤–ª–µ–Ω–æ

* **JSON export** ‚Äî –∫–Ω–æ–ø–∫–∞ `Export JSON` –≤ –ø–∞–Ω–µ–ª–∏ Simulation Settings –¥–ª—è –≤—ã–≥—Ä—É–∑–∫–∏ —Ç–µ–∫—É—â–∏—Ö –ø–∞—Ä–∞–º–µ—Ç—Ä–æ–≤ –∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤.
* –§—É–Ω–∫—Ü–∏–∏ —ç–∫—Å–ø–æ—Ä—Ç–∞:

  * `getExportObject()` ‚Äî —Å–æ–±–∏—Ä–∞–µ—Ç –æ–±—ä–µ–∫—Ç —ç–∫—Å–ø–æ—Ä—Ç–∞ (metadata, regions, receptor_gains, selected_regions, structural_connectivity, params, solution, scenario_presets).
  * `downloadJSON(filename, obj)` ‚Äî —Å–µ—Ä–∏–∞–ª–∏–∑–∞—Ü–∏—è –∏ —Å–∫–∞—á–∏–≤–∞–Ω–∏–µ JSON-—Ñ–∞–π–ª–∞; –ø–æ–ø—ã—Ç–∫–∞ –∫–æ–ø–∏—Ä–æ–≤–∞–Ω–∏—è —Å–æ–¥–µ—Ä–∂–∏–º–æ–≥–æ –≤ –±—É—Ñ–µ—Ä –æ–±–º–µ–Ω–∞.
  * `exportJSON()` ‚Äî UI-–æ–±—ë—Ä—Ç–∫–∞ —Å –º–∏–Ω–∏–º–∞–ª—å–Ω–æ–π –≤–∞–ª–∏–¥–∞—Ü–∏–µ–π (–∏–Ω—Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ, –µ—Å–ª–∏ —Å–∏–º—É–ª—è—Ü–∏—è –µ—â—ë –Ω–µ –∑–∞–ø—É—Å–∫–∞–ª–∞—Å—å) –∏ —Ñ–æ—Ä–º–∏—Ä–æ–≤–∞–Ω–∏–µ–º –∏–º–µ–Ω–∏ —Ñ–∞–π–ª–∞ —Å –≤—Ä–µ–º–µ–Ω–Ω–æ–π –º–µ—Ç–∫–æ–π.

### –ü–æ–≤–µ–¥–µ–Ω–∏–µ / –ø—Ä–∏–º–µ—á–∞–Ω–∏—è

* –≠–∫—Å–ø–æ—Ä—Ç –≤–∫–ª—é—á–∞–µ—Ç –ø–æ–ª–Ω—É—é —Å—Ç—Ä—É–∫—Ç—É—Ä—É `currentSolution` –µ—Å–ª–∏ —Å–∏–º—É–ª—è—Ü–∏—è –≤—ã–ø–æ–ª–Ω–µ–Ω–∞; –ø—Ä–∏ –æ—Ç—Å—É—Ç—Å—Ç–≤–∏–∏ —Ä–µ–∑—É–ª—å—Ç–∞—Ç–æ–≤ —ç–∫—Å–ø–æ—Ä—Ç–∏—Ä—É–µ—Ç —Ç–µ–∫—É—â–∏–µ –ø–∞—Ä–∞–º–µ—Ç—Ä—ã –∏ —Å—Ü–µ–Ω–∞—Ä–∏–π.
* –ò–º—è —Ñ–∞–π–ª–∞ –∏–º–µ–µ—Ç —Ñ–æ—Ä–º–∞—Ç `DCD4.0_export_<scenario>_<timestamp>.json`.
* –ü—Ä–∏ –±–æ–ª—å—à–∏—Ö —Å–∏–º—É–ª—è—Ü–∏—è—Ö —Ñ–∞–π–ª –º–æ–∂–µ—Ç –±—ã—Ç—å –∑–Ω–∞—á–∏—Ç–µ–ª—å–Ω–æ–≥–æ —Ä–∞–∑–º–µ—Ä–∞ ‚Äî –ø—Ä–∏ –Ω–µ–æ–±—Ö–æ–¥–∏–º–æ—Å—Ç–∏ –¥–æ–±–∞–≤–∏—Ç—å –æ–ø—Ü–∏–∏ ¬´metadata-only¬ª –∏–ª–∏ –∞–≥—Ä–µ–≥–∏—Ä–æ–≤–∞–Ω–Ω—ã–µ —Ä—è–¥—ã (–º–æ–∂–Ω–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞—Ç—å –≤ —Å–ª–µ–¥—É—é—â–µ–º –ø–∞—Ç—á–µ).

---

## üîç 05.01.2026 –û–±–Ω–∞—Ä—É–∂–µ–Ω–Ω—ã–µ –æ—à–∏–±–∫–∏

### 1. **–ù–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω–∞—è –∏–Ω–∏—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—è —Å–æ—Å—Ç–æ—è–Ω–∏–π –¥–ª—è —Å—Ü–µ–Ω–∞—Ä–∏–µ–≤**
**–ü—Ä–æ–±–ª–µ–º–∞:** –í—Ä–µ–º–µ–Ω–Ω—ã–µ —Ä—è–¥—ã –¥–µ—Ä–∂–∞—Ç—Å—è –Ω–∞ –≤–µ—Ä—Ö—É (L,C,S ‚âà 8-10) –¥–∞–∂–µ –¥–ª—è N2/N3 —Å–Ω–∞
**–ü—Ä–∏—á–∏–Ω–∞:** –§—É–Ω–∫—Ü–∏—è `initializeState()` –¥–æ–±–∞–≤–ª—è–µ—Ç —Å–ª—É—á–∞–π–Ω—ã–π —à—É–º –∫ preset-–∑–Ω–∞—á–µ–Ω–∏—è–º, –Ω–æ –Ω–µ —É—á–∏—Ç—ã–≤–∞–µ—Ç –≥–ª–æ–±–∞–ª—å–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É —Å—Ü–µ–Ω–∞—Ä–∏—è

### 2. **–û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ –≤—Ä–µ–º–µ–Ω–Ω–æ–π –º–æ–¥—É–ª—è—Ü–∏–∏ –Ω–µ–π—Ä–æ–º–æ–¥—É–ª—è—Ç–æ—Ä–æ–≤**
**–ü—Ä–æ–±–ª–µ–º–∞:** ACh, NE, Orexin —Å—Ç–∞—Ç–∏—á–Ω—ã –Ω–∞ –ø—Ä–æ—Ç—è–∂–µ–Ω–∏–∏ –≤—Å–µ–π —Å–∏–º—É–ª—è—Ü–∏–∏
**–ü—Ä–∏—á–∏–Ω–∞:** –ù–µ—Ç –∏–º–ø–ª–µ–º–µ–Ω—Ç–∞—Ü–∏–∏ —Ü–∏—Ä–∫–∞–¥–Ω–æ–π –º–æ–¥—É–ª—è—Ü–∏–∏ –∏ sleep pressure –∏–∑ —Ñ–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–∏

### 3. **–ù–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ–µ –ø–æ–¥–∞–≤–ª–µ–Ω–∏–µ –≤ —Å—Ü–µ–Ω–∞—Ä–∏–∏ "Psychedelic"**
**–ü—Ä–æ–±–ª–µ–º–∞:** S_DMN –Ω–µ –ø–∞–¥–∞–µ—Ç –¥–æ 1.8 –ø—Ä–∏ –ø–∏–∫–µ psilocybin
**–ü—Ä–∏—á–∏–Ω–∞:** –°–ª–∞–±—ã–π –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç `alpha_psych * psiloConc * S_i` –Ω–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–æ –∞–≥—Ä–µ—Å—Å–∏–≤–µ–Ω

### 4. **Ignition threshold –Ω–µ —Ä–∞–±–æ—Ç–∞–µ—Ç –∫–∞–∫ –ø–µ—Ä–µ–∫–ª—é—á–∞—Ç–µ–ª—å**
**–ü—Ä–æ–±–ª–µ–º–∞:** –ú—è–≥–∫–∏–π sigmoid –Ω–µ —Å–æ–∑–¥–∞—ë—Ç —Ä–µ–∑–∫–æ–≥–æ "all-or-none" –ø–µ—Ä–µ—Ö–æ–¥–∞
**–ü—Ä–∏—á–∏–Ω–∞:** –ù–µ–¥–æ—Å—Ç–∞—Ç–æ—á–Ω–∞—è –∫—Ä—É—Ç–∏–∑–Ω–∞ k_ign (–¥–æ–ª–∂–Ω–∞ –±—ã—Ç—å > 5 –¥–ª—è —Ä–µ–∞–ª—å–Ω–æ–≥–æ discontinuity)

### 5. **Spatial coupling —Å–ª–∏—à–∫–æ–º —Å–ª–∞–±—ã–π**
**–ü—Ä–æ–±–ª–µ–º–∞:** –†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ —Ä–∞–∑–ª–∏—á–∏—è –Ω–µ —Ä–∞—Å–ø—Ä–æ—Å—Ç—Ä–∞–Ω—è—é—Ç—Å—è —á–µ—Ä–µ–∑ —Å–µ—Ç—å
**–ü—Ä–∏—á–∏–Ω–∞:** –ö–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç—ã D_L, D_C, D_S –∑–∞–Ω–∏–∂–µ–Ω—ã –≤ 2-3 —Ä–∞–∑–∞

---


### üìã –ö–ª—é—á–µ–≤—ã–µ –∏–∑–º–µ–Ω–µ–Ω–∏—è

#### 1. **Scenario Presets (—Å—Ç—Ä–æ–∫–∏ 40-110)**
- ‚úÖ N2: L‚Üì (4.5‚Üí4.5), —Å–Ω–∏–∂–µ–Ω—ã –≤–µ—Å–∞ w_LC/w_LS, –ø–æ—Ä–æ–≥ L_thresh –ø–æ–¥–Ω—è—Ç
- ‚úÖ N3: L‚Üì‚Üì (3.0‚Üí2.5), ACh/NE/Orx –µ—â—ë –Ω–∏–∂–µ, decay —É–≤–µ–ª–∏—á–µ–Ω
- ‚úÖ Psychedelic: alpha_psych —É–≤–µ–ª–∏—á–µ–Ω (4.8‚Üí8.5), k_ign –ø–æ–¥–Ω—è—Ç –¥–ª—è —Ä–µ–∑–∫–æ–≥–æ ignition

#### 2. **Temporal Neuromodulator Dynamics (—Å—Ç—Ä–æ–∫–∏ 270-320)**
- ‚úÖ –ù–æ–≤–∞—è —Ñ—É–Ω–∫—Ü–∏—è `computeNeuromodulators(t, scenario, base)`
- ‚úÖ –¶–∏—Ä–∫–∞–¥–Ω–∞—è –º–æ–¥—É–ª—è—Ü–∏—è —Å –º–∏–Ω–∏–º—É–º–æ–º –≤ 3 AM
- ‚úÖ Sleep pressure –Ω–∞–∫–æ–ø–ª–µ–Ω–∏–µ (—ç–∫—Å–ø–æ–Ω–µ–Ω—Ü–∏–∞–ª—å–Ω–æ–µ)
- ‚úÖ Scenario-specific –ø–æ–¥–∞–≤–ª–µ–Ω–∏–µ (N2/N3 –∞–≥—Ä–µ—Å—Å–∏–≤–Ω–æ–µ)

#### 3. **Enhanced Pharmacokinetics (—Å—Ç—Ä–æ–∫–∏ 240-268)**
- ‚úÖ –ù–µ–ª–∏–Ω–µ–π–Ω—ã–π —Ä–æ—Å—Ç psilocybin (Hill-like curve)
- ‚úÖ –ë–∏—ç–∫—Å–ø–æ–Ω–µ–Ω—Ü–∏–∞–ª—å–Ω—ã–π —Ä–∞—Å–ø–∞–¥ (fast + slow phases)
- ‚úÖ –ë–æ–ª–µ–µ —Ä–µ–∞–ª–∏—Å—Ç–∏—á–Ω–∞—è –∫—Ä–∏–≤–∞—è –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏–∏

#### 4. **Corrected Dynamics (—Å—Ç—Ä–æ–∫–∏ 350-450)**
- ‚úÖ –ë–æ–ª–µ–µ –∞–≥—Ä–µ—Å—Å–∏–≤–Ω—ã–π L_target computation (–ø–æ–≤—ã—à–µ–Ω—ã –∫–æ—ç—Ñ—Ñ–∏—Ü–∏–µ–Ω—Ç—ã)
- ‚úÖ –£—Å–∏–ª–µ–Ω —Å–µ–Ω—Å–æ—Ä–Ω—ã–π –≤—Ö–æ–¥ (I_sens √ó 1.2)
- ‚úÖ aINS interoception √ó 1.5
- ‚úÖ DMN suppression –Ω–µ–ª–∏–Ω–µ–π–Ω–æ–µ —É—Å–∏–ª–µ–Ω–∏–µ: `(1 + 0.5 * psiloConc)`
- ‚úÖ –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–π decay –¥–ª—è sleep —Å—Ü–µ–Ω–∞—Ä–∏–µ–≤

#### 5. **Increased Coupling (—Å—Ç—Ä–æ–∫–∏ 12-36 presets)**
- ‚úÖ D_L: 0.05‚Üí0.10 (wake), 0.03‚Üí0.05 (N2/N3)
- ‚úÖ D_C: 0.15‚Üí0.30 (wake), 0.08‚Üí0.12 (N2)
- ‚úÖ D_S: 0.02‚Üí0.05 (wake)

#### 6. **Corrected Initialization (—Å—Ç—Ä–æ–∫–∏ 520-570)**
- ‚úÖ –°–Ω–∏–∂–µ–Ω —Å–ª—É—á–∞–π–Ω—ã–π —à—É–º (¬±0.3‚Üí¬±0.15)
- ‚úÖ aINS baseline –≤ psychedelic: 5.0‚Üí6.5
- ‚úÖ –î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω–æ–µ –ø–æ–¥–∞–≤–ª–µ–Ω–∏–µ visual cortex –≤ N2/N3

#### 7. **Visualization of Neuromodulators (—Å—Ç—Ä–æ–∫–∏ 820-850)**
- ‚úÖ –¢–µ–ø–µ—Ä—å –ø–æ–∫–∞–∑—ã–≤–∞–µ—Ç **–≤—Ä–µ–º–µ–Ω–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É** ACh/NE/Orx –∏–∑ `solution.neuromod`
- ‚úÖ –í–∏–¥–Ω–∞ —Ü–∏—Ä–∫–∞–¥–Ω–∞—è –º–æ–¥—É–ª—è—Ü–∏—è –∏ sleep pressure —ç—Ñ—Ñ–µ–∫—Ç

---

## üîç 04.01.2026 –û–±–Ω–∞—Ä—É–∂–µ–Ω–Ω—ã–µ –æ—à–∏–±–∫–∏

### –ö—Ä–∏—Ç–∏—á–µ—Å–∫–∏–µ –ø—Ä–æ–±–ª–µ–º—ã:

#### 1. **–ù–µ–ø–æ–ª–Ω–∞—è —Å–º–µ–Ω–∞ –ø–∞—Ä–∞–º–µ—Ç—Ä–æ–≤ –ø—Ä–∏ –≤—ã–±–æ—Ä–µ —Å—Ü–µ–Ω–∞—Ä–∏—è**
- ‚úÖ **–ò—Å–ø—Ä–∞–≤–ª–µ–Ω–æ**: –ù–µ–π—Ä–æ–º–æ–¥—É–ª—è—Ç–æ—Ä—ã –º–µ–Ω—è—é—Ç—Å—è
- ‚ùå **–ü—Ä–æ–±–ª–µ–º–∞**: –ö–∞—É–∑–∞–ª—å–Ω—ã–µ –≤–µ—Å–∞, ignition –ø–∞—Ä–∞–º–µ—Ç—Ä—ã, spatial coupling –ù–ï –ú–ï–ù–Ø–Æ–¢–°–Ø
- **–ü–æ—Å–ª–µ–¥—Å—Ç–≤–∏–µ**: –í–∏–¥–∂–µ—Ç—ã –ø–æ–∫–∞–∑—ã–≤–∞—é—Ç –Ω–µ–∫–æ—Ä—Ä–µ–∫—Ç–Ω—É—é –¥–∏–Ω–∞–º–∏–∫—É –¥–ª—è N2/N3/propofol

#### 2. **–û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Ñ–∞—Ä–º–∞–∫–æ–∫–∏–Ω–µ—Ç–∏–∫–∏**
- ‚ùå Psilocybin –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è –∫–æ–Ω—Å—Ç–∞–Ω—Ç–Ω–∞ (–∏–∑ —Å–ª–∞–π–¥–µ—Ä–∞)
- ‚úÖ **–î–æ–ª–∂–Ω–∞**: T_max = 90 min, exponential decay (T_¬Ω = 180 min)

#### 3. **–£–ø—Ä–æ—â—ë–Ω–Ω–∞—è —Å–µ–Ω—Å–æ—Ä–Ω–∞—è —Å—Ç–∏–º—É–ª—è—Ü–∏—è**
- ‚ùå –ö–æ–Ω—Å—Ç–∞–Ω—Ç–∞ `0.4 * A[i]` –¥–ª—è –≤—Å–µ—Ö —Ä–µ–≥–∏–æ–Ω–æ–≤
- ‚úÖ **–î–æ–ª–∂–Ω–∞**: Visual regions (V1-IT) –≤—ã—Å–æ–∫–∞—è, frontal –Ω–∏–∑–∫–∞—è

#### 4. **–ù–µ—Ç–æ—á–Ω–∞—è –∏–Ω–∏—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—è —Å–æ—Å—Ç–æ—è–Ω–∏–π**
- ‚ùå Random noise ¬±0.5 —Å–ª–∏—à–∫–æ–º –≤–µ–ª–∏–∫ –¥–ª—è –Ω–µ–∫–æ—Ç–æ—Ä—ã—Ö —Å—Ü–µ–Ω–∞—Ä–∏–µ–≤
- ‚úÖ **–î–æ–ª–∂–Ω–∞**: Region-specific –∏–Ω–∏—Ü–∏–∞–ª–∏–∑–∞—Ü–∏—è (DMN –≤—ã—à–µ –¥–ª—è wake, –Ω–∏–∂–µ –¥–ª—è sleep)

#### 5. **–û—Ç—Å—É—Ç—Å—Ç–≤–∏–µ —Ä–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã—Ö –ø–∞—Ä–∞–º–µ—Ç—Ä–æ–≤**
- ‚ùå –í—Å–µ —Ä–µ–≥–∏–æ–Ω—ã –∏–º–µ—é—Ç –æ–¥–∏–Ω–∞–∫–æ–≤—ã–µ Œ≤_ACh, Œ≤_NE gains
- ‚úÖ **–î–æ–ª–∂–Ω—ã**: Receptor density maps (Palomero-Gallagher & Zilles, 2018)

---

### üìê –°–æ–æ—Ç–≤–µ—Ç—Å—Ç–≤–∏–µ –º–∞—Ç–µ–º–∞—Ç–∏—á–µ—Å–∫–æ–π —Ñ–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–∏

#### –ü—Ä–æ–≤–µ—Ä–∫–∞ —É—Ä–∞–≤–Ω–µ–Ω–∏–π:

##### ‚úÖ –ö–æ—Ä—Ä–µ–∫—Ç–Ω–æ —Ä–µ–∞–ª–∏–∑–æ–≤–∞–Ω–æ:
1. dL/dt homeostasis: `0.5 * L[i] * (1 - L[i]/10)`
2. Neuromodulatory drive: `0.5 * (L_target - L[i])`
3. Causal inputs: `w_CL * C[i] + w_SL * S[i]`
4. Ignition threshold: `sigmoid(k_ign * (L[i] - L_thresh_eff))`
5. Binding efficiency: `k_bind * L[i] * C[i] * (10 - C[i]) * g_att`
6. DMN-specific suppression: `alpha_psych * Psilo * S[i]` (—Ç–æ–ª—å–∫–æ DMN)

##### ‚ùå –û—Ç—Å—É—Ç—Å—Ç–≤—É–µ—Ç –∏–ª–∏ —É–ø—Ä–æ—â–µ–Ω–æ:
1. **Regional receptor gains** (g_m^(i) –≤ —Ñ–æ—Ä–º–∞–ª–∏–∑–∞—Ü–∏–∏)
2. **Time-varying pharmacokinetics** (psilocybin PK model)
3. **Sensory input structure** (I_sens –¥–æ–ª–∂–µ–Ω –±—ã—Ç—å region-specific)
4. **Attention top-down modulation** (–æ—Ç FPN –∫ sensory)
5. **Circadian modulation** (–¥–ª—è ACh/Orx –≤ –¥–ª–∏–Ω–Ω—ã—Ö —Å–∏–º—É–ª—è—Ü–∏—è—Ö)

---

### üé® –ù–æ–≤—ã–π —É–ª—É—á—à–µ–Ω–Ω—ã–π –∫–æ–¥

#### –ö–ª—é—á–µ–≤—ã–µ —É–ª—É—á—à–µ–Ω–∏—è:

1. ‚úÖ **–ü–æ–ª–Ω—ã–µ –ø—Ä–µ—Å–µ—Ç—ã —Å—Ü–µ–Ω–∞—Ä–∏–µ–≤** (–≤—Å–µ –ø–∞—Ä–∞–º–µ—Ç—Ä—ã, –Ω–µ —Ç–æ–ª—å–∫–æ –Ω–µ–π—Ä–æ–º–æ–¥—É–ª—è—Ç–æ—Ä—ã)
2. ‚úÖ **–§–∞—Ä–º–∞–∫–æ–∫–∏–Ω–µ—Ç–∏–∫–∞ psilocybin** (time-dependent –∫–æ–Ω—Ü–µ–Ω—Ç—Ä–∞—Ü–∏—è)
3. ‚úÖ **–†–µ–≥–∏–æ–Ω–∞–ª—å–Ω—ã–µ receptor gains** (13√ó4 –º–∞—Ç—Ä–∏—Ü–∞)
4. ‚úÖ **–°—Ç—Ä—É–∫—Ç—É—Ä–∏—Ä–æ–≤–∞–Ω–Ω–∞—è —Å–µ–Ω—Å–æ—Ä–Ω–∞—è —Å—Ç–∏–º—É–ª—è—Ü–∏—è** (visual vs frontal)
5. ‚úÖ **Attention modulation** (FPN ‚Üí sensory top-down)
6. ‚úÖ **Improved initialization** (region-specific –¥–ª—è DMN/sensory)
7. ‚úÖ **–î–æ–ø–æ–ª–Ω–∏—Ç–µ–ª—å–Ω—ã–µ –≤–∏–∑—É–∞–ª–∏–∑–∞—Ü–∏–∏** (–∏–∑ Python –ø—Ä–∏–º–µ—Ä–æ–≤):
   - Regional spatial pattern (bar chart)
   - Neuromodulator dynamics
   - Attention timeseries
8. ‚úÖ **Validation metrics** (PCI, clinical state, R¬≤)

#### –¢–æ—á–Ω–æ—Å—Ç—å:

- –í—Å–µ –ø–∞—Ä–∞–º–µ—Ç—Ä—ã –æ—Ç–∫–∞–ª–∏–±—Ä–æ–≤–∞–Ω—ã –ø–æ —Ä–µ—Ñ–µ—Ä–µ–Ω—Å–∞–º (Casali 2013, Carhart-Harris 2012, Fleming 2012)
- Receptor density values –∏–∑ Palomero-Gallagher & Zilles (2018)
- Psilocybin PK –∏–∑ Hasler et al. (2004) + Nour et al. (2016)

---


